XML 145 R125.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule I - Condensed Financial Information of Registrant (Condensed Balance Sheets) (Details)
¥ in Thousands, $ in Thousands
Dec. 31, 2024
USD ($)
Dec. 31, 2024
CNY (¥)
Dec. 31, 2023
USD ($)
Dec. 31, 2023
CNY (¥)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Current assets:            
Cash and cash equivalents $ 2,627,410   $ 3,171,800   $ 3,869,564  
Prepaid expenses and other current assets 192,919   257,465      
Total current assets 3,991,593   4,203,414      
Other non-current assets 160,490   125,362      
Total assets 5,920,910   5,805,275      
Current liabilities:            
Accrued expenses and other payables 803,713   693,731      
Short-term debt 851,529 ¥ 6,215,538 688,366 ¥ 4,885,838    
Total current liabilities 2,214,899   1,810,113      
Non-current liabilities:            
Other long-term liabilities 66,735   50,810      
Total liabilities 2,588,688   2,267,948      
Total shareholders’ equity 3,332,222   3,537,327   $ 4,383,355 $ 6,132,563
Total liabilities and shareholders’ equity 5,920,910   5,805,275      
Parent Company            
Current assets:            
Cash and cash equivalents 400,135   723,964      
Prepaid expenses and other current assets 249,016   785,471      
Total current assets 649,151   1,509,435      
Loans to subsidiaries 1,731,266   2,030,249      
Investment in wholly owned subsidiaries 2,081,335   1,207,352      
Other non-current assets 114,728   69,361      
Total assets 4,576,480   4,816,397      
Current liabilities:            
Accrued expenses and other payables 424,111   197,289      
Research and development cost share liability, current portion 0   362,917      
Short-term debt 762,146   547,215      
Total current liabilities 1,186,257   1,107,421      
Non-current liabilities:            
Other long-term liabilities 58,000   171,649      
Total liabilities 1,244,257   1,279,070      
Total shareholders’ equity 3,332,223   3,537,327      
Total liabilities and shareholders’ equity $ 4,576,480   $ 4,816,397